Cargando…
The Importance of Endpoints in Oncology Clinical Trials
Autor principal: | Faiman, Beth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558020/ https://www.ncbi.nlm.nih.gov/pubmed/37808074 http://dx.doi.org/10.6004/jadpro.2023.14.6.1 |
Ejemplares similares
-
Oncology Advanced Practice Posters: New Research and Insights Into Our Future
por: Faiman, Beth
Publicado: (2023) -
The Importance of Professional Communities and Collaborations
por: Faiman, Beth
Publicado: (2023) -
Endpoint surrogacy in oncology Phase 3 randomised controlled trials
por: Zhang, Jianrong, et al.
Publicado: (2020) -
Quality Improvement Projects and Clinical Research Studies
por: Faiman, Beth
Publicado: (2021) -
Regarding “Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies”
por: Chabner, Bruce A.
Publicado: (2017)